The influence of systemically administered oxytocin on the implant-bone interface area: an experimental study in the rabbit
Identifieur interne : 002F04 ( Pmc/Corpus ); précédent : 002F03; suivant : 002F05The influence of systemically administered oxytocin on the implant-bone interface area: an experimental study in the rabbit
Auteurs : Sung-Am Cho ; Sang-Hun Park ; Jin-Hyun ChoSource :
- The Journal of Advanced Prosthodontics [ 2005-7806 ] ; 2014.
Abstract
The purpose of this study was to assess the effect of systemically administered oxytocin (OT) on the implant-bone interface by using histomorphometric analysis and the removal torque test.
A total of 10 adult, New Zealand white, female rabbits were used in this experiment. We placed 2 implants (CSM; CSM Implant, Daegu, South Korea) in each distal femoral metaphysis on both the right and left sides; the implants on both sides were placed 10 mm apart. In each rabbit, 1 implant was prepared for histomorphometric analysis and the other 3 were prepared for the removal torque test (RT). The animals received intramuscular injections of either saline (control group; 0.15 M NaCl) or OT (experimental group; 200 µg/rabbit). The injections were initiated on Day 3 following the implant surgery and were continued for 4 subsequent weeks; the injections were administered twice per day (at a 12-h interval), for 2 days per week.
While no statistically significant difference was observed between the two groups (
We postulate that OT supplementation via intramuscular injection weakly contributes to the bone response at the implant-bone interface in rabbits. Therefore, higher concentrations or more frequent administration of OT may be required for a greater bone response to the implant. Further studies analyzing these aspects are needed.
Url:
DOI: 10.4047/jap.2014.6.6.505
PubMed: 25551011
PubMed Central: 4279050
Links to Exploration step
PMC:4279050Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The influence of systemically administered oxytocin on the implant-bone interface area: an experimental study in the rabbit</title><author><name sortKey="Cho, Sung Am" sort="Cho, Sung Am" uniqKey="Cho S" first="Sung-Am" last="Cho">Sung-Am Cho</name><affiliation><nlm:aff id="A1">Department of Prosthodontics, School of Dentistry, Kyoungpook National University, Daegu, Republic of Korea.</nlm:aff></affiliation></author><author><name sortKey="Park, Sang Hun" sort="Park, Sang Hun" uniqKey="Park S" first="Sang-Hun" last="Park">Sang-Hun Park</name><affiliation><nlm:aff id="A1">Department of Prosthodontics, School of Dentistry, Kyoungpook National University, Daegu, Republic of Korea.</nlm:aff></affiliation></author><author><name sortKey="Cho, Jin Hyun" sort="Cho, Jin Hyun" uniqKey="Cho J" first="Jin-Hyun" last="Cho">Jin-Hyun Cho</name><affiliation><nlm:aff id="A1">Department of Prosthodontics, School of Dentistry, Kyoungpook National University, Daegu, Republic of Korea.</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25551011</idno><idno type="pmc">4279050</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279050</idno><idno type="RBID">PMC:4279050</idno><idno type="doi">10.4047/jap.2014.6.6.505</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">002F04</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002F04</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The influence of systemically administered oxytocin on the implant-bone interface area: an experimental study in the rabbit</title><author><name sortKey="Cho, Sung Am" sort="Cho, Sung Am" uniqKey="Cho S" first="Sung-Am" last="Cho">Sung-Am Cho</name><affiliation><nlm:aff id="A1">Department of Prosthodontics, School of Dentistry, Kyoungpook National University, Daegu, Republic of Korea.</nlm:aff></affiliation></author><author><name sortKey="Park, Sang Hun" sort="Park, Sang Hun" uniqKey="Park S" first="Sang-Hun" last="Park">Sang-Hun Park</name><affiliation><nlm:aff id="A1">Department of Prosthodontics, School of Dentistry, Kyoungpook National University, Daegu, Republic of Korea.</nlm:aff></affiliation></author><author><name sortKey="Cho, Jin Hyun" sort="Cho, Jin Hyun" uniqKey="Cho J" first="Jin-Hyun" last="Cho">Jin-Hyun Cho</name><affiliation><nlm:aff id="A1">Department of Prosthodontics, School of Dentistry, Kyoungpook National University, Daegu, Republic of Korea.</nlm:aff></affiliation></author></analytic><series><title level="j">The Journal of Advanced Prosthodontics</title><idno type="ISSN">2005-7806</idno><idno type="eISSN">2005-7814</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>PURPOSE</title><p>The purpose of this study was to assess the effect of systemically administered oxytocin (OT) on the implant-bone interface by using histomorphometric analysis and the removal torque test.</p></sec><sec><title>MATERIALS AND METHODS</title><p>A total of 10 adult, New Zealand white, female rabbits were used in this experiment. We placed 2 implants (CSM; CSM Implant, Daegu, South Korea) in each distal femoral metaphysis on both the right and left sides; the implants on both sides were placed 10 mm apart. In each rabbit, 1 implant was prepared for histomorphometric analysis and the other 3 were prepared for the removal torque test (RT). The animals received intramuscular injections of either saline (control group; 0.15 M NaCl) or OT (experimental group; 200 µg/rabbit). The injections were initiated on Day 3 following the implant surgery and were continued for 4 subsequent weeks; the injections were administered twice per day (at a 12-h interval), for 2 days per week.</p></sec><sec><title>RESULTS</title><p>While no statistically significant difference was observed between the two groups (<italic>P</italic>=.787), the control group had stronger removal torque values. The serum OT concentration (ELISA value) was higher in the OT-treated group, although no statistically significant difference was found. Further, the histomorphometric parameter (bone-toimplant contact [BIC], inter-thread bone, and peri-implant bone) values were higher in the experimental group, but the differences were not significant.</p></sec><sec><title>CONCLUSION</title><p>We postulate that OT supplementation via intramuscular injection weakly contributes to the bone response at the implant-bone interface in rabbits. Therefore, higher concentrations or more frequent administration of OT may be required for a greater bone response to the implant. Further studies analyzing these aspects are needed.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Adell, R" uniqKey="Adell R">R Adell</name></author><author><name sortKey="Lekholm, U" uniqKey="Lekholm U">U Lekholm</name></author><author><name sortKey="Rockler, B" uniqKey="Rockler B">B Rockler</name></author><author><name sortKey="Br Nemark, Pi" uniqKey="Br Nemark P">PI Brånemark</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cochran, Dl" uniqKey="Cochran D">DL Cochran</name></author><author><name sortKey="Morton, D" uniqKey="Morton D">D Morton</name></author><author><name sortKey="Weber, Hp" uniqKey="Weber H">HP Weber</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Le Guehennec, L" uniqKey="Le Guehennec L">L Le Guéhennec</name></author><author><name sortKey="Soueidan, A" uniqKey="Soueidan A">A Soueidan</name></author><author><name sortKey="Layrolle, P" uniqKey="Layrolle P">P Layrolle</name></author><author><name sortKey="Amouriq, Y" uniqKey="Amouriq Y">Y Amouriq</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sykaras, N" uniqKey="Sykaras N">N Sykaras</name></author><author><name sortKey="Woody, Rd" uniqKey="Woody R">RD Woody</name></author><author><name sortKey="Lacopino, Am" uniqKey="Lacopino A">AM Lacopino</name></author><author><name sortKey="Triplett, Rg" uniqKey="Triplett R">RG Triplett</name></author><author><name sortKey="Nunn, Me" uniqKey="Nunn M">ME Nunn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Blom, Ej" uniqKey="Blom E">EJ Blom</name></author><author><name sortKey="Verheij, Jg" uniqKey="Verheij J">JG Verheij</name></author><author><name sortKey="De Blieck Hogervorst, Jm" uniqKey="De Blieck Hogervorst J">JM de Blieck-Hogervorst</name></author><author><name sortKey="Di Silvio, L" uniqKey="Di Silvio L">L Di Silvio</name></author><author><name sortKey="Klein, Cp" uniqKey="Klein C">CP Klein</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stenport, Vf" uniqKey="Stenport V">VF Stenport</name></author><author><name sortKey="Olsson, B" uniqKey="Olsson B">B Olsson</name></author><author><name sortKey="Morberg, P" uniqKey="Morberg P">P Morberg</name></author><author><name sortKey="Tornell, J" uniqKey="Tornell J">J Törnell</name></author><author><name sortKey="Johansson, Cb" uniqKey="Johansson C">CB Johansson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tresguerres, If" uniqKey="Tresguerres I">IF Tresguerres</name></author><author><name sortKey="Clemente, C" uniqKey="Clemente C">C Clemente</name></author><author><name sortKey="Donado, M" uniqKey="Donado M">M Donado</name></author><author><name sortKey="G Mez Pellico, L" uniqKey="G Mez Pellico L">L Gómez-Pellico</name></author><author><name sortKey="Blanco, L" uniqKey="Blanco L">L Blanco</name></author><author><name sortKey="Alobera, Ma" uniqKey="Alobera M">MA Alobera</name></author><author><name sortKey="Tresguerres, Ja" uniqKey="Tresguerres J">JA Tresguerres</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Park, Jw" uniqKey="Park J">JW Park</name></author><author><name sortKey="Kim, Jm" uniqKey="Kim J">JM Kim</name></author><author><name sortKey="Lee, Hj" uniqKey="Lee H">HJ Lee</name></author><author><name sortKey="Jeong, Sh" uniqKey="Jeong S">SH Jeong</name></author><author><name sortKey="Suh, Jy" uniqKey="Suh J">JY Suh</name></author><author><name sortKey="Hanawa, T" uniqKey="Hanawa T">T Hanawa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tamma, R" uniqKey="Tamma R">R Tamma</name></author><author><name sortKey="Colaianni, G" uniqKey="Colaianni G">G Colaianni</name></author><author><name sortKey="Zhu, Ll" uniqKey="Zhu L">LL Zhu</name></author><author><name sortKey="Dibenedetto, A" uniqKey="Dibenedetto A">A DiBenedetto</name></author><author><name sortKey="Greco, G" uniqKey="Greco G">G Greco</name></author><author><name sortKey="Montemurro, G" uniqKey="Montemurro G">G Montemurro</name></author><author><name sortKey="Patano, N" uniqKey="Patano N">N Patano</name></author><author><name sortKey="Strippoli, M" uniqKey="Strippoli M">M Strippoli</name></author><author><name sortKey="Vergari, R" uniqKey="Vergari R">R Vergari</name></author><author><name sortKey="Mancini, L" uniqKey="Mancini L">L Mancini</name></author><author><name sortKey="Colucci, S" uniqKey="Colucci S">S Colucci</name></author><author><name sortKey="Grano, M" uniqKey="Grano M">M Grano</name></author><author><name sortKey="Faccio, R" uniqKey="Faccio R">R Faccio</name></author><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author><author><name sortKey="Li, J" uniqKey="Li J">J Li</name></author><author><name sortKey="Usmani, S" uniqKey="Usmani S">S Usmani</name></author><author><name sortKey="Bachar, M" uniqKey="Bachar M">M Bachar</name></author><author><name sortKey="Bab, I" uniqKey="Bab I">I Bab</name></author><author><name sortKey="Nishimori, K" uniqKey="Nishimori K">K Nishimori</name></author><author><name sortKey="Young, Lj" uniqKey="Young L">LJ Young</name></author><author><name sortKey="Buettner, C" uniqKey="Buettner C">C Buettner</name></author><author><name sortKey="Iqbal, J" uniqKey="Iqbal J">J Iqbal</name></author><author><name sortKey="Sun, L" uniqKey="Sun L">L Sun</name></author><author><name sortKey="Zaidi, M" uniqKey="Zaidi M">M Zaidi</name></author><author><name sortKey="Zallone, A" uniqKey="Zallone A">A Zallone</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Colaianni, G" uniqKey="Colaianni G">G Colaianni</name></author><author><name sortKey="Di Benedetto, A" uniqKey="Di Benedetto A">A Di Benedetto</name></author><author><name sortKey="Zhu, Ll" uniqKey="Zhu L">LL Zhu</name></author><author><name sortKey="Tamma, R" uniqKey="Tamma R">R Tamma</name></author><author><name sortKey="Li, J" uniqKey="Li J">J Li</name></author><author><name sortKey="Greco, G" uniqKey="Greco G">G Greco</name></author><author><name sortKey="Peng, Y" uniqKey="Peng Y">Y Peng</name></author><author><name sortKey="Dell Ndice, S" uniqKey="Dell Ndice S">S Dell›Endice</name></author><author><name sortKey="Zhu, G" uniqKey="Zhu G">G Zhu</name></author><author><name sortKey="Cuscito, C" uniqKey="Cuscito C">C Cuscito</name></author><author><name sortKey="Grano, M" uniqKey="Grano M">M Grano</name></author><author><name sortKey="Colucci, S" uniqKey="Colucci S">S Colucci</name></author><author><name sortKey="Iqbal, J" uniqKey="Iqbal J">J Iqbal</name></author><author><name sortKey="Yuen, T" uniqKey="Yuen T">T Yuen</name></author><author><name sortKey="Sun, L" uniqKey="Sun L">L Sun</name></author><author><name sortKey="Zaidi, M" uniqKey="Zaidi M">M Zaidi</name></author><author><name sortKey="Zallone, A" uniqKey="Zallone A">A Zallone</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Colli, Vc" uniqKey="Colli V">VC Colli</name></author><author><name sortKey="Okamoto, R" uniqKey="Okamoto R">R Okamoto</name></author><author><name sortKey="Spritzer, Pm" uniqKey="Spritzer P">PM Spritzer</name></author><author><name sortKey="Dornelles, Rc" uniqKey="Dornelles R">RC Dornelles</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Amar, Ap" uniqKey="Amar A">AP Amar</name></author><author><name sortKey="Weiss, Mh" uniqKey="Weiss M">MH Weiss</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, Hj" uniqKey="Lee H">HJ Lee</name></author><author><name sortKey="Macbeth, Ah" uniqKey="Macbeth A">AH Macbeth</name></author><author><name sortKey="Pagani, Jh" uniqKey="Pagani J">JH Pagani</name></author><author><name sortKey="Young, Ws" uniqKey="Young W">WS Young</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Colaianni, G" uniqKey="Colaianni G">G Colaianni</name></author><author><name sortKey="Tamma, R" uniqKey="Tamma R">R Tamma</name></author><author><name sortKey="Di Benedetto, A" uniqKey="Di Benedetto A">A Di Benedetto</name></author><author><name sortKey="Yuen, T" uniqKey="Yuen T">T Yuen</name></author><author><name sortKey="Sun, L" uniqKey="Sun L">L Sun</name></author><author><name sortKey="Zaidi, M" uniqKey="Zaidi M">M Zaidi</name></author><author><name sortKey="Zallone, A" uniqKey="Zallone A">A Zallone</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Breuil, V" uniqKey="Breuil V">V Breuil</name></author><author><name sortKey="Amri, Ez" uniqKey="Amri E">EZ Amri</name></author><author><name sortKey="Panaia Ferrari, P" uniqKey="Panaia Ferrari P">P Panaia-Ferrari</name></author><author><name sortKey="Testa, J" uniqKey="Testa J">J Testa</name></author><author><name sortKey="Elabd, C" uniqKey="Elabd C">C Elabd</name></author><author><name sortKey="Albert Sabonnadiere, C" uniqKey="Albert Sabonnadiere C">C Albert-Sabonnadière</name></author><author><name sortKey="Roux, Ch" uniqKey="Roux C">CH Roux</name></author><author><name sortKey="Ailhaud, G" uniqKey="Ailhaud G">G Ailhaud</name></author><author><name sortKey="Dani, C" uniqKey="Dani C">C Dani</name></author><author><name sortKey="Carle, Gf" uniqKey="Carle G">GF Carle</name></author><author><name sortKey="Euller Ziegler, L" uniqKey="Euller Ziegler L">L Euller-Ziegler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Petersson, M" uniqKey="Petersson M">M Petersson</name></author><author><name sortKey="Lagumdzija, A" uniqKey="Lagumdzija A">A Lagumdzija</name></author><author><name sortKey="Stark, A" uniqKey="Stark A">A Stark</name></author><author><name sortKey="Bucht, E" uniqKey="Bucht E">E Bucht</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Luo, T" uniqKey="Luo T">T Luo</name></author><author><name sortKey="Zhang, W" uniqKey="Zhang W">W Zhang</name></author><author><name sortKey="Shi, B" uniqKey="Shi B">B Shi</name></author><author><name sortKey="Cheng, X" uniqKey="Cheng X">X Cheng</name></author><author><name sortKey="Zhang, Y" uniqKey="Zhang Y">Y Zhang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="G Mez Moreno, G" uniqKey="G Mez Moreno G">G Gómez-Moreno</name></author><author><name sortKey="Cutando, A" uniqKey="Cutando A">A Cutando</name></author><author><name sortKey="Arana, C" uniqKey="Arana C">C Arana</name></author><author><name sortKey="Worf, Cv" uniqKey="Worf C">CV Worf</name></author><author><name sortKey="Guardia, J" uniqKey="Guardia J">J Guardia</name></author><author><name sortKey="Mu Oz, F" uniqKey="Mu Oz F">F Muñoz</name></author><author><name sortKey="Lopez Pe A, M" uniqKey="Lopez Pe A M">M Lopez-Peña</name></author><author><name sortKey="Stephenson, J" uniqKey="Stephenson J">J Stephenson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author><author><name sortKey="Shimono, K" uniqKey="Shimono K">K Shimono</name></author><author><name sortKey="Zhu, Ll" uniqKey="Zhu L">LL Zhu</name></author><author><name sortKey="Li, J" uniqKey="Li J">J Li</name></author><author><name sortKey="Peng, Y" uniqKey="Peng Y">Y Peng</name></author><author><name sortKey="Imam, A" uniqKey="Imam A">A Imam</name></author><author><name sortKey="Iqbal, J" uniqKey="Iqbal J">J Iqbal</name></author><author><name sortKey="Moonga, S" uniqKey="Moonga S">S Moonga</name></author><author><name sortKey="Colaianni, G" uniqKey="Colaianni G">G Colaianni</name></author><author><name sortKey="Su, C" uniqKey="Su C">C Su</name></author><author><name sortKey="Lu, Z" uniqKey="Lu Z">Z Lu</name></author><author><name sortKey="Iwamoto, M" uniqKey="Iwamoto M">M Iwamoto</name></author><author><name sortKey="Pacifici, M" uniqKey="Pacifici M">M Pacifici</name></author><author><name sortKey="Zallone, A" uniqKey="Zallone A">A Zallone</name></author><author><name sortKey="Sun, L" uniqKey="Sun L">L Sun</name></author><author><name sortKey="Zaidi, M" uniqKey="Zaidi M">M Zaidi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Macdonald, E" uniqKey="Macdonald E">E MacDonald</name></author><author><name sortKey="Dadds, Mr" uniqKey="Dadds M">MR Dadds</name></author><author><name sortKey="Brennan, Jl" uniqKey="Brennan J">JL Brennan</name></author><author><name sortKey="Williams, K" uniqKey="Williams K">K Williams</name></author><author><name sortKey="Levy, F" uniqKey="Levy F">F Levy</name></author><author><name sortKey="Cauchi, Aj" uniqKey="Cauchi A">AJ Cauchi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="I Eri, So" uniqKey="I Eri S">SO Işeri</name></author><author><name sortKey="Sener, G" uniqKey="Sener G">G Sener</name></author><author><name sortKey="Saglam, B" uniqKey="Saglam B">B Saglam</name></author><author><name sortKey="Gedik, N" uniqKey="Gedik N">N Gedik</name></author><author><name sortKey="Ercan, F" uniqKey="Ercan F">F Ercan</name></author><author><name sortKey="Yegen, Bc" uniqKey="Yegen B">BC Yegen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Petersson, M" uniqKey="Petersson M">M Petersson</name></author><author><name sortKey="Lagumdzija, A" uniqKey="Lagumdzija A">A Lagumdzija</name></author><author><name sortKey="Stark, A" uniqKey="Stark A">A Stark</name></author><author><name sortKey="Bucht, E" uniqKey="Bucht E">E Bucht</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ryden, G" uniqKey="Ryden G">G Rydén</name></author><author><name sortKey="Sjoholm, I" uniqKey="Sjoholm I">I Sjöholm</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Adv Prosthodont</journal-id><journal-id journal-id-type="iso-abbrev">J Adv Prosthodont</journal-id><journal-id journal-id-type="publisher-id">JAP</journal-id><journal-title-group><journal-title>The Journal of Advanced Prosthodontics</journal-title></journal-title-group><issn pub-type="ppub">2005-7806</issn><issn pub-type="epub">2005-7814</issn><publisher><publisher-name>The Korean Academy of Prosthodontics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25551011</article-id><article-id pub-id-type="pmc">4279050</article-id><article-id pub-id-type="doi">10.4047/jap.2014.6.6.505</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The influence of systemically administered oxytocin on the implant-bone interface area: an experimental study in the rabbit</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Sung-Am</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Sang-Hun</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cho</surname><given-names>Jin-Hyun</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib></contrib-group><aff id="A1">Department of Prosthodontics, School of Dentistry, Kyoungpook National University, Daegu, Republic of Korea.</aff><author-notes><corresp>Corresponding author: Jin-Hyun Cho. Department of Prosthodontics, School of Dentistry, Kyoungpook National University, #2175 Dalgubeoldae-ro, Jung-gu, Daegu 700-705, Republic of Korea. Tel. 82 53 600 7675: <email>prosth95@knu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2014</year></pub-date><volume>6</volume><issue>6</issue><fpage>505</fpage><lpage>511</lpage><history><date date-type="received"><day>26</day><month>3</month><year>2014</year></date><date date-type="rev-recd"><day>16</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>05</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>© 2014 The Korean Academy of Prosthodontics</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>PURPOSE</title><p>The purpose of this study was to assess the effect of systemically administered oxytocin (OT) on the implant-bone interface by using histomorphometric analysis and the removal torque test.</p></sec><sec><title>MATERIALS AND METHODS</title><p>A total of 10 adult, New Zealand white, female rabbits were used in this experiment. We placed 2 implants (CSM; CSM Implant, Daegu, South Korea) in each distal femoral metaphysis on both the right and left sides; the implants on both sides were placed 10 mm apart. In each rabbit, 1 implant was prepared for histomorphometric analysis and the other 3 were prepared for the removal torque test (RT). The animals received intramuscular injections of either saline (control group; 0.15 M NaCl) or OT (experimental group; 200 µg/rabbit). The injections were initiated on Day 3 following the implant surgery and were continued for 4 subsequent weeks; the injections were administered twice per day (at a 12-h interval), for 2 days per week.</p></sec><sec><title>RESULTS</title><p>While no statistically significant difference was observed between the two groups (<italic>P</italic>=.787), the control group had stronger removal torque values. The serum OT concentration (ELISA value) was higher in the OT-treated group, although no statistically significant difference was found. Further, the histomorphometric parameter (bone-toimplant contact [BIC], inter-thread bone, and peri-implant bone) values were higher in the experimental group, but the differences were not significant.</p></sec><sec><title>CONCLUSION</title><p>We postulate that OT supplementation via intramuscular injection weakly contributes to the bone response at the implant-bone interface in rabbits. Therefore, higher concentrations or more frequent administration of OT may be required for a greater bone response to the implant. Further studies analyzing these aspects are needed.</p></sec></abstract><kwd-group><kwd>Oxytocin</kwd><kwd>Removal torque test</kwd><kwd>Histomorphometric parameter</kwd><kwd>Dental implant</kwd></kwd-group><funding-group><award-group><funding-source country="KR">Kyungpook National University Hospital</funding-source></award-group></funding-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Osseointegration is a vital process that occurs during bone healing and formation of new bone. It is defined as "a direct structural and functional connection between ordered, living bone and the surface of the load-carrying implant".<xref rid="B1" ref-type="bibr">1</xref> The conventional 2-stage approach for implantation was first reported by Bränemark et al. in 1969. In the first stage, the mucosa is reflected, implants and cover screws are placed, and the surgical site is sutured. After approximately 4 to 6 months, a second surgery is performed in which the transmucosal abutments are connected. However, this conventional implant protocol proposed by Bränemark has undergone changes over time. Currently, patients whose conditions are favorable for implantation (bone volume and height) undergo the immediate loading protocol in which installation and prosthetic activation are carried out within a 48-h period.<xref rid="B2" ref-type="bibr">2</xref> This treatment option has been developed in order to assuage the patient's masticatory disability and for esthetic issues during the healing period. The osseointegration rate of titanium dental implants is related to their composition and surface roughness.<xref rid="B3" ref-type="bibr">3</xref> With respect to the composition, a recent advancement involves loading the surface of implants with molecules such as recombinant human bone morphogenetic protein-2 (rhBMP-2) that controls the bone remodeling process and thereby enhances the healing process.<xref rid="B4" ref-type="bibr">4</xref> In addition, growth hormone (GH) is used as a growth factor to promote implant integration.<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref> In this regard, the importance of oxytocin (OT) as a potential growth factor that can be used to promote bone healing has been suggested.<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref></p><p><italic>In vivo</italic>, OT has long been shown to be one of the most important regulators of uterine contraction during parturition and milk ejection throughout lactation.<xref rid="B12" ref-type="bibr">12</xref> This peptide is produced in the hypothalamus, whereupon it passes to the neurohypophysis via the 100,000 nerve fibers comprising the hypothalamo-hypophyseal tract. From the posterior lobe, the hormone is released into the general blood circulation in response to electrical activity at the axon endings.<xref rid="B12" ref-type="bibr">12</xref> Oxytocin has effects in addition to uterine contraction and lactation, such as social bonding, appetite regulation, sexual behavior, trust, and bone regulation.<xref rid="B13" ref-type="bibr">13</xref> In bone regulation, the absence of OT or the OT receptor (Oxtr) in male or female subjects results in reduced bone formation, leading to osteoporosis. OT signal is transduced via Oxtr, which is express in variety of tissues including myoblasts, osteoclasts and osteoblasts.<xref rid="B14" ref-type="bibr">14</xref> OT stimulates the formation of bone by stimulating osteoblasts to a mineralizing phenotype by upregulating BMP-2 through the <italic>Schnurri-2</italic>, <italic>Osterix</italic> and <italic>ATF-4</italic> expression.<xref rid="B9" ref-type="bibr">9</xref> OT also plays an important role in osteoclast formation by activating NF-kappaB and MAP kinase pathway directly, and by up-regulating receptor activator nuclear factor-kappaB ligand (RANK-L) indirectly.<xref rid="B9" ref-type="bibr">9</xref> The positive effects of OT on rat and human osteoblast-like cells in OTand Oxtr-deficient bone defects suggest the fundamentally important role of this peptide in skeletal physiology.<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref> Thus, OT could also promote bonding between the implant and bone, and could be considered as a growth factor. Recently, Colli et al.<xref rid="B11" ref-type="bibr">11</xref> reported that intraperitoneal (ip) injection of OT promoted bone formation and inhibited bone resorption in aged, acyclic female rats during the alveolar healing process. Therefore, OT might be considered as a growth factor in the alveolar bone healing process. We hypothesized that systemically administered OT could promote bone formation at the implant-bone interface, thereby improving implant stability during the early healing period.</p><p>The objectives of the present study were to assess whether histological differences appear in the peri-implant bone with the intramuscular injection of OT after surgery, estimate the plasma OT level, evaluate quantitatively the peri-implant bone response via morphometric analysis (such as bone-to-implant contact [BIC] area), and perform the removal torque test at the implant-bone interface (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><p>A total of 10 adult, New Zealand white, female rabbits were used in this experiment, which was approved by the local animal ethics committee at the Kyungpook National University, South Korea (IRB 2012-129). The rabbits were divided into two groups (5 rabbits in each group) and were assigned to plastic cages (1 rabbit/cage). The mean weight was 2.8 (± 0.5) kg before the surgery and 3.0 (± 0.5) kg when the animals were killed. The animals were anesthetized using intramuscular injections of ketamine (Ketar; Yuhan Corporation, Seoul, South Korea; 44 mg/kg) and xylazine (Rompun; Bayer Korea, Seoul, South Korea; 68 mg/kg). Before surgery, 1.8 mL of 2% lidocaine (Yuhan Corporation, Seoul, South Korea) was injected locally into the surgical sites. Postoperatively, each rabbit received enofloxacine (Baytril; Bayer Korea), methampyrone (Novin-50; Bayer Korea), and butaphosphan (Catosal; Bayer Korea), each at a dose of 0.3 mL per animal for 3 days.</p><p>The sequence of implant placement, oxytocin administration, and blood culture are followings. Prior to the surgery, the skin was cleaned with a mixture of iodine and 75% ethanol, and the femoral metaphysis was exposed. The skin and fascia, muscle, and periosteal flap were reflected, and the bone was denuded. Low speed rotary handpiece and saline cooling were used during all surgical procedures. An implant (3.75 × 4 mm) with a resorbable blasted media (RBM) surface was used. A 3-mm-diameter drill was used to drill a hole with 4 mm in depth in the bone. Tapping or countersink drills were not used in this study. We placed 2 implants (CSM; CSM Implant, Daegu, South Korea) in each distal femoral metaphysis on the right and left sides (Ru = right upper, Rl = right lower, Lu = left upper, Ll = left lower); the implants on the right and left sides were placed 10 mm apart. In each rabbit, one implant (Ru) was prepared for histomorphometric analysis, and the other 3 were used for the removal torque test (RT). All implants penetrated only the first cortical layer, never engaging the opposite cortical bone. After insertion, the fascia and skin were closed in separate layers by using absorbable sutures (4-0 Vicryl®; Ethicon Inc., Somerville, MA, USA). Intramuscular injections of saline (control group; 0.15 M NaCl) or OT (experimental group; 200 µg/rabbit) were administered 3 days after implant surgery for 4 subsequent weeks; the injections were administered twice per day (at a 12-h interval) for 2 days per week.<xref rid="B11" ref-type="bibr">11</xref> The OT dose (Sigma-Aldrich, St. Louis, MO, USA) was determined based on the findings of a previous study.<xref rid="B11" ref-type="bibr">11</xref> OT was diluted with distilled water (200 µg/mL), and 1 mL was administered intramuscularly to each rabbit (2 times/2 days/week). At 31 days after surgery, blood was collected from the ear vessel, and the animals were subsequently sacrificed using an overdose of carbon dioxide (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p><p>The removal torque forces of 15 dental implants were measured, while 5 implants (Ru) were used for histological analysis in each group. After a healing period of 31 days, all 10 rabbits were sacrificed, and the removal torque test was subsequently conducted. An incision was made, the soft tissues were reflected, and the implant site was denuded. After careful removal of the overgrown bone above the screw, an MGT-12 digital torque gauge (Mark-10 Corp, New York, NY, USA) was used to measure the removal torque with a connector specifically made to connect the torque gauge and the fixture. The results were recorded by measuring the maximum torque at which fracture occurred between the implant and the bone (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p><p>Serum OT was measured using an OT ELISA kit (Assay Designs/Enzo Life Sciences, Ann Arbor, MI, USA) according to the manufacturer's instructions. To explain the process briefly, 50 µL of rabbit serum was diluted in 150 µL of assay buffer and was subsequently incubated with the OT ELISA plate at 4℃ overnight. Excess reagents were washed away and the substrate was added. Various concentrations of standard OT were also incubated for the calculation. After incubation, the enzymatic reaction was stopped and the color intensity was read on a microplate reader at 405 nm. The OT concentrations (pg/mL) were calculated from the standard curve.</p><p>In Histological and histomorphometic analysis, a total of 10 implants were used for histological evaluation. The implant-tissue block was removed, fixed with 10% neutral formalin solution, and stained with Villanueva bone stain for 7 days. After dehydration in a graded ethanol series (70, 80, 95, and 100% infiltration with a mixture of isopropanol and epoxy resin 812), the sample was embedded in epoxy resin 812 and polymerized in an oven at 60℃ for 7 days. The polymerized block was cut using a hard tissue-cutting machine (Accutom-50; Struers, Copenhagen, Denmark) under constant cooling. The non-decalcified sections had an initial thickness of approximately 150 µm and were successively ground to a thickness of approximately 50 µm by using a grinding machine (Rotopol-35; Struers, Copenhagen, Denmark). The sections were then examined under a microscope (Olympus, Tokyo, Japan).</p><p>The BIC area was determined by linear measurement of direct bone contact with the implant surface. The BIC image was captured using a digital camera (Olympus, Tokyo, Japan) connected to the microscope at a magnification of 40× (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Using the IMT image analysis software (i-Solution; IMTechnology Inc., Daejeon, Korea), the sum of the linear bone contact with the implant surface was calculated and was expressed as a percentage of the total implant length. The inter-thread bone density was defined as the area of bone inside the threads (×100%) by using the 4 most central threads in the lateral and median sections (<xref ref-type="fig" rid="F3">Fig. 3</xref>). The percentage of peri-implant bone area was defined as the area of bone that had formed after implant insertion/rectangular area (×100%) (1 mm × 1.2 mm rectangle; 2 rectangles per implant) (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p><p>The Mann-Whitney U test was used to identify the difference in removal torque values between the experimental and the control groups. The paired <italic>t</italic>-test was used to evaluate the difference in the level of serum OT between the two groups. The <italic>t</italic>-test was subsequently performed to examine the differences in BIC, peri-implant bone area, and inter-thread bone density values between the control and experimental groups. The values are reported as mean ± SD. All statistical analyses were performed using PASW 18.0 for Windows (SPSS Inc., Chicago, IL, USA), with <italic>P</italic><.05 set as the level of significance.</p></sec><sec sec-type="results"><title>RESULTS</title><p>The measured removal torque values are summarized in <xref ref-type="table" rid="T1">Table 1</xref>. The mean value of the removal torque force for the control group was 30.04 ± 17.02 N·cm, whereas that of the experimental group was 28.06 ± 10.21 N·cm. No significant difference was observed between the two groups (<italic>P</italic>=.787). However, the control group had higher values than those of the experimental group (<xref ref-type="fig" rid="F4">Fig. 4</xref>).</p><p>The measured serum OT concentration values are summarized in <xref ref-type="table" rid="T2">Table 2</xref>. The OT concentrations (pg/mL) were calculated from the standard curve. The mean value of the experimental group was 936.81 pg/mL and that of the control group was 705.89 pg/mL. No significant difference was observed between the two groups (<xref ref-type="fig" rid="F5">Fig. 5</xref>).</p><p>The values of the different histomorphometric parameters of osseointegration at 31 days (4 weeks + 3 days) after implantation are shown in <xref ref-type="table" rid="T3">Table 3</xref>. The values were higher in the experimental group than in the control group, but no significant differences were found between the two groups. The BIC values were higher in the experimental group (30.33% ± 13.11%) than in the control group (20.58% ± 9.81%), and the inter-thread bone density values were also higher in the experimental group (67.04% ± 12.06%) than in the control group (54.40% ± 29.66%); however, neither of these findings were statistically significant. The periimplant bone area value was 59.36% ± 11.74% in the experimental group compared to 48.39% ± 23.93% in the control group, but this difference was also not statistically significant</p><p>Representative images of the dental implant at 31 days in both the OT-treated and the control samples, with new bone formation between all threads are shown in <xref ref-type="fig" rid="F6">Figures 6A and B</xref>. The histomorphometric cross-sectional view of an implant in an OT-treated sample (<xref ref-type="fig" rid="F6">Fig. 6A</xref>) corresponding to the peri-implant bone area in which it was observed shows a similar percentage of bone tissue in contact with the implant when compared with similar sections in a control sample (<xref ref-type="fig" rid="F6">Fig. 6B</xref>).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>A variety of substances have been used to enhance the peri-implant bone response: growth factors, morphogenetic proteins, and recently, hormones such as growth hormone.<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref> Regarding the potential effect of OT on bone formation, Tamma et al.<xref rid="B9" ref-type="bibr">9</xref> found that deletion of OT or the Oxtr in male or female mice causes osteoporosis resulting from reduced bone formation. OT stimulates osteoblast differentiation and increases osteoblastic bone formation; thus, reductions in these processes account for the osteopenic phenotype of OT deficiency, in which no discernible alterations in osteoclast numbers are observed on histomorphometry.<xref rid="B9" ref-type="bibr">9</xref> This hormone has dual effects on the osteoclast: it stimulates osteoclast formation, but inhibits bone resorption by mature osteoclasts by triggering cytosolic Ca<sup>2+</sup> release and NO synthesis.<xref rid="B9" ref-type="bibr">9</xref> Colli et al.<xref rid="B11" ref-type="bibr">11</xref> reported that OT promotes bone formation and inhibits bone resorption in aged, acyclic female rats during the alveolar healing process. Their study showed that the levels of the plasma biochemical bone formation markers, alkaline phosphatase (ALP) and osteocalcin were significantly higher in the experimental group. The experimental group had the highest mean post-extraction bone formation values on histomorphometric analyses, and tartrate-resistant acid phosphatase (TRAP) levels were significantly reduced in this group, representing the anti-resorptive effect of OT.<xref rid="B11" ref-type="bibr">11</xref> Another study showed that mice lacking OT and Oxtr displayed severe osteoporosis due to the defective bone formation effect, suggesting the expanding roles of OT in bone remodeling.<xref rid="B19" ref-type="bibr">19</xref></p><p>The optimal dosage and the side effects of OT, however, must also be considered. Excessive dosage or long-term administration (over a period of 24 hours or longer) have been shown to result in tetanic uterine contractions, uterine rupture, postpartum hemorrhage, and water intoxication in humans, whereas little is known regarding the effects on animals. The pharmacology and the possible side effects of intravenous infusion of synthetic OT are accessible from the United States Food and Drug Association (USFDA) database. However, relatively high doses of intranasal OT in humans seem to have few side effects, indicating that OT is safe to use clinically.<xref rid="B20" ref-type="bibr">20</xref> Injection of 5 to 20 IU (1 IU of OT is the equivalent of approximately 2 µg of pure peptide) is commonly used clinically to induce labor and milk ejection.<xref rid="B21" ref-type="bibr">21</xref> In rats, 1000 µg/kg of OT was used to demonstrate the anti-inflammatory functions of OT, and no significant side effects were observed.<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref> Further, OT is destroyed in the gastrointestinal tract, and it has a typical half-life of about 3 to 5 minutes in the blood.<xref rid="B23" ref-type="bibr">23</xref> Moreover, the injected OT does not cross the blood-brain barrier. This indicates that oral administration of OT would not be sufficient and repeated injection of OT may be required to have an effect on peripheral tissues.</p><p>Regarding another local delivery method of OT, Park et al.<xref rid="B8" ref-type="bibr">8</xref> reported that the OT-loaded β-tricalcium phosphate (β-TCP) delivered directly as a bone substitute promoted bone formation via an osteoinductive mode of action; thus, this method offers the possibility of achieving predictable bone regeneration in osseous defects (such as through sinus bone graft and the guided bone regeneration [GBR] procedure).</p><p>In our study, we evaluated the bone-forming capacity of OT using the removal torque test and histomorphometric analyses in rabbits that were administered with systemic OT. Intramuscular injections of saline (control group; 0.15 M NaCl) or OT (experimental group; 200 µg/rabbit) were administered 3 days after implant surgery for 4 subsequent weeks; the injections were given twice per day (at a 12-h interval) for 2 days per week.<xref rid="B11" ref-type="bibr">11</xref> The intramuscular route of administration was chosen because it is convenient for evaluating the effects of OT on the interface between the implant and bone. As a method of determining implantbone bonding, the removal torque test is a destructive technique that provides a direct reading of the stability at the implant-tissue interface. The peak torque necessary to loosen the implant from the bone bed was measured in N·cm, which is a rough estimate of the interfacial shear strength of the implant attachment. The present study showed no difference between the experimental and control groups, although the torque value was slightly higher in the control group. In the histomorphometric analysis, the histomorphometric parameter values were higher in the experimental group, although the difference did not reach statistical significance.</p><p>Several factors may explain the lack of significant differences in the removal torque test and histomorphometric analysis results. While the serum OT concentration (ELISA value) was higher in the OT-treated group, the increase was not significant, which could be attributed to the degradation of OT in the blood and serum. Further, the injected OT might not have been high or frequent enough to cross the threshold level. As mentioned earlier, the half-life of OT is typically about 3 to 5 minutes in the blood; therefore, the amount of OT that reached the implant site may have been too low to have sufficient influence on the bone at the implant-bone interface. An optimum high concentration or more frequent administration of OT, which should be safe enough for human, may be required to elicit a greater bone response to the implant and further studies are needed to elucidate these aspects. We observed several increments in the histomorphometric parameter values, suggesting that OT contributed weakly to the bone response at the implantbone interface. Therefore, further studies using other hormones or an Oxtr agonist are needed to confirm the increase in the removal torque and the implant-bone interface response.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In this study of the influence of systemically administered OT on the implant-bone interface, no significant differences in the removal torque test and histomorphometric analysis results were observed. We observed some increments in the histomorphometric parameter values. An optimum high concentration or more frequent administration of OT, which should be safe enough for human, may be required to elicit a greater bone response to the implant and further studies are needed to understand these aspects. This study is the first trial to investigate the effect of systemically administered OT on the implant-bone interface and can therefore serve as an experimental model to improve further OT-related investigations.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We thank to Prof. Heon-Jin Lee for a comprehensive consultation regarding OT.</p></ack><fn-group><fn fn-type="supported-by"><p>This work was supported by Biomedical Research Institute Grant, Kyungpook National University Hospital (2012).</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adell</surname><given-names>R</given-names></name><name><surname>Lekholm</surname><given-names>U</given-names></name><name><surname>Rockler</surname><given-names>B</given-names></name><name><surname>Brånemark</surname><given-names>PI</given-names></name></person-group><article-title>A 15-year study of osseointegrated implants in the treatment of the edentulous jaw</article-title><source>Int J Oral Surg</source><year>1981</year><volume>10</volume><fpage>387</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">6809663</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cochran</surname><given-names>DL</given-names></name><name><surname>Morton</surname><given-names>D</given-names></name><name><surname>Weber</surname><given-names>HP</given-names></name></person-group><article-title>Consensus statements and recommended clinical procedures regarding loading protocols for endosseous dental implants</article-title><source>Int J Oral Maxillofac Implants</source><year>2004</year><volume>19</volume><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">15635951</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Guéhennec</surname><given-names>L</given-names></name><name><surname>Soueidan</surname><given-names>A</given-names></name><name><surname>Layrolle</surname><given-names>P</given-names></name><name><surname>Amouriq</surname><given-names>Y</given-names></name></person-group><article-title>Surface treatments of titanium dental implants for rapid osseointegration</article-title><source>Dent Mater</source><year>2007</year><volume>23</volume><fpage>844</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">16904738</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sykaras</surname><given-names>N</given-names></name><name><surname>Woody</surname><given-names>RD</given-names></name><name><surname>Lacopino</surname><given-names>AM</given-names></name><name><surname>Triplett</surname><given-names>RG</given-names></name><name><surname>Nunn</surname><given-names>ME</given-names></name></person-group><article-title>Osseointegration of dental implants complexed with rh-BMP-2: a comparative histomorphometric and radiographic evaluation</article-title><source>Int J Oral Maxillofac Implants</source><year>2004</year><volume>19</volume><fpage>667</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">15508982</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blom</surname><given-names>EJ</given-names></name><name><surname>Verheij</surname><given-names>JG</given-names></name><name><surname>de Blieck-Hogervorst</surname><given-names>JM</given-names></name><name><surname>Di Silvio</surname><given-names>L</given-names></name><name><surname>Klein</surname><given-names>CP</given-names></name></person-group><article-title>Cortical bone ingrowth in growth hormone-loaded grooved implants with calcium phosphate coatings in goat femurs</article-title><source>Biomaterials</source><year>1998</year><volume>19</volume><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">9678875</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenport</surname><given-names>VF</given-names></name><name><surname>Olsson</surname><given-names>B</given-names></name><name><surname>Morberg</surname><given-names>P</given-names></name><name><surname>Törnell</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>CB</given-names></name></person-group><article-title>Systemically administered human growth hormone improves initial implant stability: an experimental study in the rabbit</article-title><source>Clin Implant Dent Relat Res</source><year>2001</year><volume>3</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">11799703</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tresguerres</surname><given-names>IF</given-names></name><name><surname>Clemente</surname><given-names>C</given-names></name><name><surname>Donado</surname><given-names>M</given-names></name><name><surname>Gómez-Pellico</surname><given-names>L</given-names></name><name><surname>Blanco</surname><given-names>L</given-names></name><name><surname>Alobera</surname><given-names>MA</given-names></name><name><surname>Tresguerres</surname><given-names>JA</given-names></name></person-group><article-title>Local administration of growth hormone enhances periimplant bone reaction in an osteoporotic rabbit model</article-title><source>Clin Oral Implants Res</source><year>2002</year><volume>13</volume><fpage>631</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">12519338</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Jeong</surname><given-names>SH</given-names></name><name><surname>Suh</surname><given-names>JY</given-names></name><name><surname>Hanawa</surname><given-names>T</given-names></name></person-group><article-title>Bone healing with oxytocin-loaded microporous β-TCP bone substitute in ectopic bone formation model and critical-sized osseous defect of rat</article-title><source>J Clin Periodontol</source><year>2014</year><volume>41</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">24256613</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamma</surname><given-names>R</given-names></name><name><surname>Colaianni</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>LL</given-names></name><name><surname>DiBenedetto</surname><given-names>A</given-names></name><name><surname>Greco</surname><given-names>G</given-names></name><name><surname>Montemurro</surname><given-names>G</given-names></name><name><surname>Patano</surname><given-names>N</given-names></name><name><surname>Strippoli</surname><given-names>M</given-names></name><name><surname>Vergari</surname><given-names>R</given-names></name><name><surname>Mancini</surname><given-names>L</given-names></name><name><surname>Colucci</surname><given-names>S</given-names></name><name><surname>Grano</surname><given-names>M</given-names></name><name><surname>Faccio</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Usmani</surname><given-names>S</given-names></name><name><surname>Bachar</surname><given-names>M</given-names></name><name><surname>Bab</surname><given-names>I</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Buettner</surname><given-names>C</given-names></name><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zaidi</surname><given-names>M</given-names></name><name><surname>Zallone</surname><given-names>A</given-names></name></person-group><article-title>Oxytocin is an anabolic bone hormone</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>7149</fpage><lpage>7154</lpage><pub-id pub-id-type="pmid">19369205</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colaianni</surname><given-names>G</given-names></name><name><surname>Di Benedetto</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>LL</given-names></name><name><surname>Tamma</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Greco</surname><given-names>G</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Dell›Endice</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Cuscito</surname><given-names>C</given-names></name><name><surname>Grano</surname><given-names>M</given-names></name><name><surname>Colucci</surname><given-names>S</given-names></name><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Yuen</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zaidi</surname><given-names>M</given-names></name><name><surname>Zallone</surname><given-names>A</given-names></name></person-group><article-title>Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts</article-title><source>Biochem Biophys Res Commun</source><year>2011</year><volume>411</volume><fpage>512</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">21741363</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colli</surname><given-names>VC</given-names></name><name><surname>Okamoto</surname><given-names>R</given-names></name><name><surname>Spritzer</surname><given-names>PM</given-names></name><name><surname>Dornelles</surname><given-names>RC</given-names></name></person-group><article-title>Oxytocin promotes bone formation during the alveolar healing process in old acyclic female rats</article-title><source>Arch Oral Biol</source><year>2012</year><volume>57</volume><fpage>1290</fpage><lpage>1297</lpage><pub-id pub-id-type="pmid">22525945</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amar</surname><given-names>AP</given-names></name><name><surname>Weiss</surname><given-names>MH</given-names></name></person-group><article-title>Pituitary anatomy and physiology</article-title><source>Neurosurg Clin N Am</source><year>2003</year><volume>14</volume><fpage>11</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">12690976</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Macbeth</surname><given-names>AH</given-names></name><name><surname>Pagani</surname><given-names>JH</given-names></name><name><surname>Young</surname><given-names>WS</given-names><suffix>3rd</suffix></name></person-group><article-title>Oxytocin: the great facilitator of life</article-title><source>Prog Neurobiol</source><year>2009</year><volume>88</volume><fpage>127</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">19482229</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colaianni</surname><given-names>G</given-names></name><name><surname>Tamma</surname><given-names>R</given-names></name><name><surname>Di Benedetto</surname><given-names>A</given-names></name><name><surname>Yuen</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zaidi</surname><given-names>M</given-names></name><name><surname>Zallone</surname><given-names>A</given-names></name></person-group><article-title>The oxytocin-bone axis</article-title><source>J Neuroendocrinol</source><year>2014</year><volume>26</volume><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">24219627</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breuil</surname><given-names>V</given-names></name><name><surname>Amri</surname><given-names>EZ</given-names></name><name><surname>Panaia-Ferrari</surname><given-names>P</given-names></name><name><surname>Testa</surname><given-names>J</given-names></name><name><surname>Elabd</surname><given-names>C</given-names></name><name><surname>Albert-Sabonnadière</surname><given-names>C</given-names></name><name><surname>Roux</surname><given-names>CH</given-names></name><name><surname>Ailhaud</surname><given-names>G</given-names></name><name><surname>Dani</surname><given-names>C</given-names></name><name><surname>Carle</surname><given-names>GF</given-names></name><name><surname>Euller-Ziegler</surname><given-names>L</given-names></name></person-group><article-title>Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition</article-title><source>Joint Bone Spine</source><year>2011</year><volume>78</volume><fpage>611</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">21441053</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersson</surname><given-names>M</given-names></name><name><surname>Lagumdzija</surname><given-names>A</given-names></name><name><surname>Stark</surname><given-names>A</given-names></name><name><surname>Bucht</surname><given-names>E</given-names></name></person-group><article-title>Oxytocin stimulates proliferation of human osteoblast-like cells</article-title><source>Peptides</source><year>2002</year><volume>23</volume><fpage>1121</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">12126740</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>B</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery</article-title><source>Clin Oral Implants Res</source><year>2012</year><volume>23</volume><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">21443590</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Moreno</surname><given-names>G</given-names></name><name><surname>Cutando</surname><given-names>A</given-names></name><name><surname>Arana</surname><given-names>C</given-names></name><name><surname>Worf</surname><given-names>CV</given-names></name><name><surname>Guardia</surname><given-names>J</given-names></name><name><surname>Muñoz</surname><given-names>F</given-names></name><name><surname>Lopez-Peña</surname><given-names>M</given-names></name><name><surname>Stephenson</surname><given-names>J</given-names></name></person-group><article-title>The effects of growth hormone on the initial bone formation around implants</article-title><source>Int J Oral Maxillofac Implants</source><year>2009</year><volume>24</volume><fpage>1068</fpage><lpage>1073</lpage><pub-id pub-id-type="pmid">20162111</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Shimono</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>LL</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Imam</surname><given-names>A</given-names></name><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Moonga</surname><given-names>S</given-names></name><name><surname>Colaianni</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Iwamoto</surname><given-names>M</given-names></name><name><surname>Pacifici</surname><given-names>M</given-names></name><name><surname>Zallone</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zaidi</surname><given-names>M</given-names></name></person-group><article-title>Oxytocin deficiency impairs maternal skeletal remodeling</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>388</volume><fpage>161</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">19653998</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>E</given-names></name><name><surname>Dadds</surname><given-names>MR</given-names></name><name><surname>Brennan</surname><given-names>JL</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Levy</surname><given-names>F</given-names></name><name><surname>Cauchi</surname><given-names>AJ</given-names></name></person-group><article-title>A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research</article-title><source>Psychoneuroendocrinology</source><year>2011</year><volume>36</volume><fpage>1114</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">21429671</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Işeri</surname><given-names>SO</given-names></name><name><surname>Sener</surname><given-names>G</given-names></name><name><surname>Saglam</surname><given-names>B</given-names></name><name><surname>Gedik</surname><given-names>N</given-names></name><name><surname>Ercan</surname><given-names>F</given-names></name><name><surname>Yegen</surname><given-names>BC</given-names></name></person-group><article-title>Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils</article-title><source>J Surg Res</source><year>2005</year><volume>126</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">15916978</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersson</surname><given-names>M</given-names></name><name><surname>Lagumdzija</surname><given-names>A</given-names></name><name><surname>Stark</surname><given-names>A</given-names></name><name><surname>Bucht</surname><given-names>E</given-names></name></person-group><article-title>Oxytocin stimulates proliferation of human osteoblast-like cells</article-title><source>Peptides</source><year>2002</year><volume>23</volume><fpage>1121</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">12126740</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rydén</surname><given-names>G</given-names></name><name><surname>Sjöholm</surname><given-names>I</given-names></name></person-group><article-title>Half-life of oxytocin in blood of pregnant and non-pregnant women</article-title><source>Acta Endocrinol (Copenh)</source><year>1969</year><volume>61</volume><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">5820054</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Intramuscular injections (oxytocin or saline) were given 2 times/2 days/week and animals were sacrificed at 31 days after surgery.</p></caption><graphic xlink:href="jap-6-505-g001"></graphic></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>An MGT-12 digital torque gauge (Mark-10 Corp, New York, NY, USA) was used to measure the removal torque with a connector specifically made to connect the torque gauge and the fixture.</p></caption><graphic xlink:href="jap-6-505-g002"></graphic></fig><fig id="F3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>The inter-thread bone density was defined as the area of bone inside the 4 most-central threads (×100%). The percentage of peri-implant bone area was defined as the area of bone that had formed after implant insertion/rectangular area (×100%) (1 mm × 1.2 mm rectangle; 2 rectangles per implant). The bone-to-implant contact (BIC) was determined by linear measurement of direct bone contact with the implant surface.</p></caption><graphic xlink:href="jap-6-505-g003"></graphic></fig><fig id="F4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Mean values of the removal torque force for the control and experimental groups. No statistically significant difference was observed between the two groups (<italic>P</italic>=.787), although the control group showed higher values.</p></caption><graphic xlink:href="jap-6-505-g004"></graphic></fig><fig id="F5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Oxytocin concentrations (pg/mL) were calculated from the standard curve. The mean value for the experimental group was 936.81 pg/mL and that of the control group was 705.89 pg/mL; the values were not significantly different.</p></caption><graphic xlink:href="jap-6-505-g005"></graphic></fig><fig id="F6" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Representative images at 31 days after dental implantation in an oxytocin (OT)-treated and a control sample with new bone formation between all threads. The histomorphometric cross-sectional view of an implant in an OT-treated sample (A) corresponding to the peri-implant bone area in which it was observed shows a similar percentage of bone tissue in contact with the implant when compared with similar sections in a control sample (B).</p></caption><graphic xlink:href="jap-6-505-g006"></graphic></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of the measured removal torque values</p></caption><graphic xlink:href="jap-6-505-i001"></graphic></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Summary of the measured serum oxytocin concentration values</p></caption><graphic xlink:href="jap-6-505-i002"></graphic><table-wrap-foot><fn><p>The oxytocin concentrations (pg/mL) were calculated from the standard curve.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Values of the histomorphometric parameters of osseointegration at 31 days (4 weeks + 3 days) after implantation. Although the values were higher in the experimental group, no significant differences were observed between the two groups</p></caption><graphic xlink:href="jap-6-505-i003"></graphic></table-wrap></floats-group></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002F04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:4279050
|texte= The influence of systemically administered oxytocin on the implant-bone interface area: an experimental study in the rabbit
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:25551011" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |